Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health, Inc. (NYSE: EVH) regularly issues news and updates that reflect its focus on better health outcomes for people with complex conditions and on specialty care solutions for payers and providers. Company news often highlights developments in oncology and other complex specialties, financial performance, strategic transactions and leadership changes.
Investors and industry observers following EVH news can expect recurring coverage of quarterly and annual financial results, including revenue and adjusted EBITDA metrics and management commentary on demand for complex specialty care solutions. Evolent frequently reaffirms or updates its financial guidance through press releases and related 8-K filings, and schedules conference calls and webcasts to discuss these results.
Evolent’s news flow also features clinical and partnership initiatives. For example, the company has announced a national partnership with American Oncology Network to introduce a model for cancer care that seeks to improve quality and affordability while reducing reliance on prior authorization. This model incorporates quality initiatives, AI-driven clinical insights through the MiBA analytics platform, payment innovation, and care navigation programs that use a cancer care management platform to support patients.
Corporate and capital markets announcements form another key part of EVH news. Recent items include the pricing and issuance of 4.50% convertible senior notes due 2031, repurchases of existing convertible notes and Class A common stock, and amendments to credit agreements and commitment letters for incremental financing facilities. Evolent also publishes updates on strategic portfolio actions, such as the divestiture of its value-based primary care business, Evolent Care Partners, to Privia Health Group, Inc.
Governance and leadership updates appear in the news as well, including appointments to executive roles, changes in the Chief Financial Officer position, and board retirements and appointments. For readers tracking EVH, this news page offers an ongoing view into how the company communicates its financial performance, specialty care initiatives, capital structure decisions and organizational evolution.
Evolent Health, Inc. (EVH) reported a GAAP revenue of $215.1 million for Q1 2021, marking a decrease from $221.2 million in Q1 2020. The company achieved an Adjusted EBITDA of $14.9 million, up from $3.9 million year-on-year. A net loss attributable to shareholders was $(9.8) million, an improvement from $(78.8) million in 2020. Evolent is managing approximately 11.6 million lives and has announced new partnerships to enhance its service offerings. CEO Seth Blackley expressed optimism about the company's trajectory towards organic growth and margin expansion.
Evolent Health, listed on NYSE as EVH, announced its participation in the 2021 Bank of America Health Care Conference. Scheduled for May 13, 2021, at 2:00 p.m. ET, CEO Seth Blackley and CFO John Johnson will present. Investors can access a live webcast on the company's investor relations page. Evolent Health specializes in clinical and administrative solutions aimed at improving health care efficiency and affordability, serving a diverse range of payers and providers nationally.
Evolent Health (NYSE: EVH) will announce its first quarter 2021 operating results on May 5, 2021, after market close. A conference call is scheduled for 6:00 p.m. Eastern Time, where shareholders can participate by dialing 855.940.9467 or 412.317.6034 for international callers. An audio playback will be accessible on Evolent's investor relations website for one week post-call.
Evolent offers clinical and administrative solutions aimed at enhancing healthcare affordability and efficiency, serving a national client base of payers and providers.
Evolent Health is launching a Covid-19 vaccine video education program in partnership with various Black community leaders at Quinn Chapel AME in Chicago. This initiative aims to reach up to 1 million Black and Latinx congregants over Easter weekend, addressing vaccine myths and encouraging vaccinations. The program will feature personal stories from faith leaders and will be shared across 500 faith communities. Evolent has a history of supporting local health initiatives and aims to bridge care gaps exacerbated by the pandemic.
Evolent Health (NYSE: EVH) reported 40% growth in the population served by its Evolent Care Partners network compared to 2020. Key drivers include new partnerships, regional expansion in Texas, and growth with existing partners. The network now consists of ~500 primary care physicians, a 30% increase from last year, managing approximately 90,000 lives under Medicare Advantage and Commercial plans, equating to about $900M in premium equivalent. The company emphasizes its innovative technology and clinical programs that improve care coordination and cost management, even during the pandemic.
Evolent Health reported a 15.0% increase in GAAP revenue for Q4 2020, totaling $271.9 million, and a 20.8% increase for the full year, reaching $1.02 billion. The company posted a net loss of $(14.6) million for Q4 and $(334.2) million for the year. Adjusted EBITDA improved to $16.1 million for Q4 and $41.4 million for the year. Strategic growth was evident with new partnerships, such as with Blue Cross Blue Shield of Texas, bolstering their market position. Evolent aims for continued momentum in 2021, focusing on capital allocation and operational efficiencies.
Evolent Health (NYSE: EVH) announced that CEO Seth Blackley and CFO John Johnson will participate in the Cowen 41st Annual Health Care Conference. Their virtual presentation is scheduled for March 3, 2021, at 3:20 p.m. ET. A live audio webcast will be available on Evolent's investor relations site. Evolent Health focuses on delivering clinical and administrative solutions to enhance whole-person health. The company is recognized for its innovative cost management and has received the NCQA Population Health Program Accreditation.
Evolent Health (NYSE: EVH) will announce its fourth quarter and full year 2020 operating results on February 25, 2021, after market close. A conference call will follow at 5:00 p.m. Eastern Time, where shareholders and participants can dial in to listen. The company offers clinical and administrative solutions to improve health care efficiency. Evolent has received the National Committee for Quality Assurance's Population Health Program Accreditation and is recognized as a leading workplace in health care.
Evolent Health (NYSE: EVH) announced the appointment of Kim A. Keck to its Board of Directors, effective immediately. Keck, with over 30 years of health care experience, replaces retiring board member Bruce Felt. As President and CEO of the Blue Cross Blue Shield Association, she brings valuable insights to Evolent during a critical growth phase. The company also named Cheryl Scott as Lead Independent Director. Evolent aims to enhance its clinical and administrative solutions while maximizing shareholder value.
Evolent Health (NYSE: EVH) has announced a definitive agreement with Bright HealthCare to acquire True Health New Mexico, a wholly-owned subsidiary of Evolent. The transaction, expected to close in the first half of 2021, aims to enhance Evolent's operational framework, while continuing to provide health plan support to True Health New Mexico. Evolent's CEO, Seth Blackley, highlighted the focus on creating shareholder value through organic revenue growth and margin expansion. Current employees of True Health New Mexico will join Bright HealthCare, ensuring continuity in market operations.